SON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sonoco Products Co (SON) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the stock has some positive catalysts, such as bullish analyst ratings and technical indicators, the lack of significant trading signals, weak financial performance in the latest quarter, and absence of recent news or event-driven catalysts make it less compelling for immediate entry.
The technical indicators are moderately positive. The MACD is above 0 and positively contracting, suggesting a bullish trend. The RSI is neutral at 60.303, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 57.848 and 59.649, while support levels are at 52.019 and 50.218. However, the stock's short-term trend indicates a 40% chance of declining by -0.34% in the next day, -2.06% in the next week, and -4.71% in the next month.
Analyst ratings are bullish, with multiple firms raising price targets significantly. For example, Citi raised its target to $70, and Truist raised it to $69, both maintaining Buy ratings. The company's Investor Day highlighted structural cost improvements and volume growth potential. Technical indicators also show a bullish trend.
The company's latest financial performance is weak, with a significant drop in net income (-873.37% YoY), EPS (-856.82% YoY), and gross margin (-15.50% YoY). There is no recent news or event-driven catalysts, and hedge fund and insider trading trends are neutral. Additionally, the stock's short-term trend suggests potential declines in the coming days and weeks.
In Q4 2025, revenue increased significantly by 379.81% YoY to $1.77 billion, but net income dropped by -873.37% YoY to $332.24 million. EPS also fell sharply by -856.82% YoY to 3.33, and gross margin decreased to 19.63% (-15.50% YoY). While revenue growth is impressive, profitability metrics are concerning.
Analyst sentiment is generally positive, with multiple firms raising price targets and maintaining Buy ratings. For example, Citi raised its target to $70, Truist to $69, and BofA to $68, citing structural cost improvements and volume growth. However, UBS and Baird remain Neutral, and Wells Fargo downgraded the stock to Equal Weight, citing a lack of catalysts and concerns about sluggish fundamentals.
